HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kazuhiro Sentani Selected Research

Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)

6/2022Essential Roles of TDO2 in Gastric Cancer: TDO2 Is Associated with Cancer Progression, Patient Survival, PD-L1 Expression, and Cancer Stem Cells.
12/2021TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer.
1/2018TDO2 Overexpression Is Associated with Cancer Stem Cells and Poor Prognosis in Esophageal Squamous Cell Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kazuhiro Sentani Research Topics

Disease

63Neoplasms (Cancer)
06/2022 - 08/2007
26Stomach Neoplasms (Stomach Cancer)
03/2021 - 08/2007
15Colorectal Neoplasms (Colorectal Cancer)
03/2022 - 01/2010
14Carcinoma (Carcinomatosis)
03/2022 - 01/2004
11Prostatic Neoplasms (Prostate Cancer)
01/2021 - 01/2009
10Renal Cell Carcinoma (Grawitz Tumor)
10/2021 - 03/2013
9Neoplasm Metastasis (Metastasis)
06/2022 - 01/2004
8Urinary Bladder Neoplasms (Bladder Cancer)
07/2022 - 10/2011
8Carcinogenesis
07/2019 - 01/2004
6Adenocarcinoma
10/2020 - 08/2008
4Breast Neoplasms (Breast Cancer)
06/2022 - 01/2015
4Infections
06/2022 - 01/2016
4Adenoma (Adenomas)
01/2019 - 06/2013
3Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
06/2022 - 01/2016
3Esophageal Squamous Cell Carcinoma
01/2020 - 03/2011
3Microsatellite Instability
07/2019 - 08/2015
3Metaplasia
01/2019 - 02/2012
3Gastritis
01/2019 - 07/2012
3Esophageal Neoplasms (Esophageal Cancer)
01/2014 - 04/2010
2Coronary Artery Disease (Coronary Atherosclerosis)
03/2021 - 03/2018
2Fibrosis (Cirrhosis)
01/2021 - 02/2014
2Inflammation (Inflammations)
01/2019 - 01/2015
2Atherosclerosis
03/2018 - 08/2013
2Radiation-Induced Neoplasms (Neoplasms, Radiation Induced)
02/2017 - 01/2015
2Atrophic Gastritis
01/2016 - 02/2012
2Polyps
01/2015 - 06/2013
1Squamous Cell Neoplasms (Squamous Cell Cancer)
04/2022
1Hepatocellular Carcinoma (Hepatoma)
04/2022
1Peritonitis
11/2021
1Disease Progression
06/2021
1Vascular Remodeling
03/2021
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2021
1Non-Muscle Invasive Bladder Neoplasms
01/2021
1Mesothelioma
12/2020
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
10/2020
1Ovarian Neoplasms (Ovarian Cancer)
10/2020
1Endometriosis
10/2020

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
01/2022 - 04/2008
14Biomarkers (Surrogate Marker)IBA
04/2022 - 01/2009
10MucinsIBA
05/2022 - 08/2008
9Ampicillin (Omnipen)FDA LinkGeneric
02/2017 - 07/2010
8Biological ProductsIBA
01/2019 - 01/2004
7MicroRNAs (MicroRNA)IBA
01/2019 - 10/2011
5Sunitinib (Sutent)FDA Link
10/2021 - 10/2017
5Docetaxel (Taxotere)FDA Link
01/2021 - 08/2007
4Messenger RNA (mRNA)IBA
03/2021 - 01/2004
4DNA (Deoxyribonucleic Acid)IBA
07/2019 - 08/2015
4ParaffinIBA
01/2019 - 03/2013
4Formaldehyde (Formol)FDA Link
01/2019 - 03/2013
4CateninsIBA
01/2019 - 01/2012
3EnzymesIBA
06/2022 - 03/2011
3Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA
06/2022 - 01/2018
3CytokinesIBA
01/2020 - 02/2012
3Small Interfering RNA (siRNA)IBA
07/2014 - 01/2014
3olfactomedinIBA
06/2013 - 11/2009
2Tryptophan (L-Tryptophan)FDA Link
06/2022 - 01/2018
2Anti-Bacterial Agents (Antibiotics)IBA
11/2021 - 01/2016
2Cisplatin (Platino)FDA LinkGeneric
10/2021 - 05/2019
2KinesinsIBA
10/2021 - 07/2021
2Fluorouracil (Carac)FDA LinkGeneric
07/2021 - 03/2009
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2021 - 04/2020
2Prostate-Specific Antigen (Semenogelase)IBA
01/2021 - 01/2013
2OligonucleotidesIBA
10/2020 - 05/2016
2AntigensIBA
10/2020 - 08/2007
2Hormones (Hormone)IBA
10/2020 - 04/2010
2Interleukin-6 (Interleukin 6)IBA
01/2020 - 01/2019
2Androgen Receptors (Androgen Receptor)IBA
05/2019 - 11/2017
2spasmolytic polypeptideIBA
01/2019 - 02/2012
2Vascular Endothelial Growth Factor CIBA
01/2015 - 12/2013
2InterferonsIBA
05/2013 - 03/2013
2Cadherins (E-Cadherin)IBA
09/2012 - 10/2011
2Tumor Biomarkers (Tumor Markers)IBA
03/2011 - 01/2009
1Phenobarbital (Luminal)FDA Link
07/2022
1Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA
06/2022
1Bevacizumab (Avastin)FDA Link
04/2022
1lenvatinibIBA
04/2022
1atezolizumabIBA
04/2022
1Fructose-Bisphosphate Aldolase (Aldolase)IBA
03/2022
1PlatinumIBA
02/2022
1Cetuximab (Erbitux)FDA Link
12/2021
1Aldehyde Dehydrogenase 1 FamilyIBA
12/2021
1hydrogen rich salineIBA
11/2021
1AnticoagulantsIBA
11/2021
1CalciumIBA
03/2021
1Hydroxyproline (4 Hydroxyproline)IBA
01/2021
1IntegrinsIBA
01/2021
1AdipokinesIBA
12/2020
1Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2020
1CarbohydratesIBA
10/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2020
1Estrogens (Estrogen)FDA Link
10/2020

Therapy/Procedure

13Therapeutics
06/2022 - 05/2013
11Drug Therapy (Chemotherapy)
02/2022 - 02/2007
4Castration
01/2021 - 01/2014
4Nephrectomy
04/2020 - 03/2013
2Hepatectomy
07/2020 - 12/2016
2Adjuvant Chemotherapy
10/2017 - 12/2013
1Molecular Targeted Therapy
04/2022
1Transurethral Resection of Bladder
01/2021
1Orchiectomy (Orchidectomy)
10/2020